Simon Goodacre

1.4k total citations
13 papers, 513 citations indexed

About

Simon Goodacre is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Simon Goodacre has authored 13 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Simon Goodacre's work include Neuroscience and Neuropharmacology Research (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Synthesis and Biological Evaluation (3 papers). Simon Goodacre is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Synthesis and Biological Evaluation (3 papers). Simon Goodacre collaborates with scholars based in United Kingdom, United States and Switzerland. Simon Goodacre's co-authors include David J. Hallett, José L. Castro, John Atack, Steve Thomas, Keith A. Wafford, Kevin J. Merchant, Alexander C. Humphries, Emanuela Gancia, James Crawforth and Andrew Pike and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Neuropharmacology.

In The Last Decade

Simon Goodacre

13 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Goodacre United Kingdom 11 334 176 88 62 29 13 513
Thierry Godel Switzerland 10 424 1.3× 262 1.5× 122 1.4× 58 0.9× 26 0.9× 11 618
F. Moureau Belgium 9 216 0.6× 154 0.9× 143 1.6× 43 0.7× 14 0.5× 17 512
Matthias V. Westphal Switzerland 7 264 0.8× 193 1.1× 98 1.1× 82 1.3× 12 0.4× 11 496
Richard T. Beresis United States 15 399 1.2× 228 1.3× 75 0.9× 28 0.5× 13 0.4× 19 602
Cesarino Balsamini Italy 13 402 1.2× 210 1.2× 90 1.0× 27 0.4× 10 0.3× 34 590
C. P. Dell United Kingdom 15 584 1.7× 231 1.3× 77 0.9× 29 0.5× 8 0.3× 37 850
Paul Blundell United States 14 293 0.9× 192 1.1× 212 2.4× 23 0.4× 18 0.6× 20 554
Neil D. Miller United Kingdom 15 355 1.1× 218 1.2× 112 1.3× 15 0.2× 14 0.5× 22 548
Matthias Nettekoven Switzerland 17 309 0.9× 250 1.4× 93 1.1× 41 0.7× 78 2.7× 35 663
Bradley W. Caprathe United States 14 558 1.7× 299 1.7× 77 0.9× 25 0.4× 48 1.7× 25 781

Countries citing papers authored by Simon Goodacre

Since Specialization
Citations

This map shows the geographic impact of Simon Goodacre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Goodacre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Goodacre more than expected).

Fields of papers citing papers by Simon Goodacre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Goodacre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Goodacre. The network helps show where Simon Goodacre may publish in the future.

Co-authorship network of co-authors of Simon Goodacre

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Goodacre. A scholar is included among the top collaborators of Simon Goodacre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Goodacre. Simon Goodacre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gazzard, Lewis, B.A. Appleton, Kerry L. Chapman, et al.. (2014). Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1. Bioorganic & Medicinal Chemistry Letters. 24(24). 5704–5709. 15 indexed citations
2.
Blackaby, Wesley, Richard T. Lewis, Simon Goodacre, et al.. (2010). Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1. ACS Medicinal Chemistry Letters. 1(7). 350–354. 14 indexed citations
3.
Blackaby, Wesley, Simon Goodacre, Andrew Pike, et al.. (2009). Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2235–2239. 7 indexed citations
4.
Humphries, Alexander C., Emanuela Gancia, Simon Goodacre, et al.. (2006). 8-Fluoroimidazo[1,2-a]pyridine: Synthesis, physicochemical properties and evaluation as a bioisosteric replacement for imidazo[1,2-a]pyrimidine in an allosteric modulator ligand of the GABAA receptor. Bioorganic & Medicinal Chemistry Letters. 16(6). 1518–1522. 96 indexed citations
5.
Blackaby, Wesley, John Atack, Frances A. Bromidge, et al.. (2006). Imidazo[1,2-a]pyrimidines as functionally selective GABAA ligands. Bioorganic & Medicinal Chemistry Letters. 16(5). 1175–1179. 36 indexed citations
6.
Atack, John, Andy Pike, George Marshall, et al.. (2006). The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone. Neuropharmacology. 50(6). 677–689. 14 indexed citations
7.
Fradley, Rosa, Martin R. Guscott, David J. Hallett, et al.. (2006). Differential contribution of GABAA receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands. Journal of Psychopharmacology. 21(4). 384–391. 43 indexed citations
8.
Goodacre, Simon, David J. Hallett, Robert W. Carling, et al.. (2005). Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as α2/α3 subtype selective GABAA agonists for the treatment of anxiety. Bioorganic & Medicinal Chemistry Letters. 16(6). 1582–1585. 19 indexed citations
9.
Goodacre, Simon, Leslie J. Street, David J. Hallett, et al.. (2005). Imidazo[1,2-a]pyrimidines as Functionally Selective and Orally Bioavailable GABAAα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders. Journal of Medicinal Chemistry. 49(1). 35–38. 121 indexed citations
10.
Rowley, Michael, David J. Hallett, Simon Goodacre, et al.. (2001). 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as High Affinity, Selective, and Orally Bioavailable h5-HT2A Receptor Antagonists. Journal of Medicinal Chemistry. 44(10). 1603–1614. 93 indexed citations
11.
Crawforth, James, Simon Goodacre, Smita S. Patel, et al.. (2000). 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists. Bioorganic & Medicinal Chemistry Letters. 10(24). 2701–2703. 10 indexed citations
12.
Hallett, David J., Ute Gerhard, Simon Goodacre, et al.. (2000). Neighboring Group Participation of the Indole Nucleus:  An Unusual DAST-Mediated Rearrangement Reaction. The Journal of Organic Chemistry. 65(16). 4984–4993. 24 indexed citations
13.
Street, Leslie J., Simon Goodacre, Sarah C. Hobbs, et al.. (1999). 3-(Piperazinylpropyl)indoles:  Selective, Orally Bioavailable h5-HT1DReceptor Agonists as Potential Antimigraine Agents. Journal of Medicinal Chemistry. 42(4). 691–705. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026